Biological E Limited has technology partnerships with Ohio State University College of Veterinary Medicine and the #Baylor College of Medicine and is evaluating additional technology platforms.

https://www.bioprocessonline.com/doc/what-role-will-india-play-in-the-global-covid-vaccine-narrative-0001

Another company based in #Hyderabad, Biological E Limited, has been producing vaccines for 58 years.

Its candidate for the COVID-19 pandemic is based on classical vaccine technology: a protein antigen, SARS-CoV-2 Spike RBD, adsorbed to the adjuvant Alhydrogel (Alum), in combination with a second adjuvant, CpG 101.

The company expects to complete Phase 2 trials by the end of Q1 2021.

It also has technology partnerships with Ohio State University College of Veterinary Medicine and the #Baylor College of Medicine and is evaluating additional technology platforms.

classical vaccine technology #recombinantProtein